# Panzyga

NDC: 0069-1011
Generic name: immune globulin intravenous (human)
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190809

FDA application: BLA125587

## Active ingredients

- HUMAN IMMUNOGLOBULIN G: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-1011"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-1011